atenolol has been researched along with isradipine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 11 (45.83) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| McGrath, BP; McNeil, JJ; Silagy, CA | 1 |
| Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Kullman, S; Scherstén, B; Sivertsson, R; Sörensen, S | 1 |
| Meisner, W; Reiterer, W | 1 |
| Jespersen, LT; Krusell, LR; Pedersen, OL; Sihm, I | 1 |
| Gleerup, G; Mehlsen, J; Winther, K | 1 |
| Baume, RM; Colton, T; Croog, SH; Elias, MF; Hall, WD; Jenkins, CD; Leiblum, SR; Perry, HM | 1 |
| Bartels, DW; Benz, JR; Due, DL; Hall, WD; Kostis, JB; Peng, A; Perry, HM; Sirgo, M; Townsend, RR | 1 |
| Gleerup, G; Haedersdal, C; Mehlsen, J; Winther, K | 1 |
| Bailey, KL; Eckermann, AJ; Kahler, K; Rendell, MS; Shehan, MA | 1 |
| Carney, S; Gillies, A; Mason, A; McPherson, J; Smith, A; Taylor, M | 1 |
| Hietanen, EK; Kantola, IM; Kataja, MJ; Pelttari, LH; Salo, TT | 1 |
| Kantola, I; Pelttari, L; Salo, TM; Viikari, JS; Voipio-Pulkki, LM | 1 |
| Betekhtina, VA; Rakov, SS | 1 |
| Calil, VM; Darcie, S; Kahhale, S; Leone, CR; Prescinotti, EP; Zugaib, M | 1 |
| Kostin, VI; Koturga, LI; Shangina, OA | 1 |
1 review(s) available for atenolol and isradipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 trial(s) available for atenolol and isradipine
| Article | Year |
|---|---|
Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitors; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male | 1992 |
Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Humans; Hypertension; Isradipine; Middle Aged; Prospective Studies; Quality of Life; Safety; Sweden | 1991 |
Effect of isradipine and atenolol on lung function in patients with mild essential hypertension.
Topics: Adult; Aged; Airway Resistance; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Female; Forced Expiratory Volume; Humans; Hypertension; Isradipine; Lung; Male; Middle Aged; Pilot Projects; Pyridines | 1991 |
A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
Topics: Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Pyridines; Random Allocation | 1989 |
Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Isradipine; Male; Middle Aged; Placebos; Pyridines; Random Allocation; Vascular Resistance | 1989 |
Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
Topics: Adult; Aged; Atenolol; beta-Thromboglobulin; Blood Platelets; Blood Pressure; Cross-Over Studies; Double-Blind Method; Exercise; Female; Fibrinolysis; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Radioimmunoassay | 1995 |
Effects of antihypertensive medications on quality of life in elderly hypertensive women.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Isradipine; Quality of Life; Time Factors | 1994 |
Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
Topics: Aged; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Potassium; Prospective Studies | 1994 |
Beneficial effect of isradipine on the development of left ventricular hypertrophy in mild hypertension.
Topics: Aged; Atenolol; Blood Pressure; Double-Blind Method; Exercise Tolerance; Heart Rate; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Isradipine; Male; Middle Aged; Treatment Outcome; Ventricular Function, Left | 1993 |
Effect of calcium channel blockade on skin blood flow in diabetic hypertension: a comparison of isradipine and atenolol.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diabetic Angiopathies; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Regional Blood Flow; Skin | 1997 |
Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; beta-Thromboglobulin; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Hemorrhage; Humans; Hypertension; Isradipine; Male; Middle Aged | 1997 |
Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1998 |
The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Enalapril; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors | 1999 |
Glycemia in newborns of hypertensive mothers according to maternal treatment.
Topics: Antihypertensive Agents; Apgar Score; Atenolol; Blood Glucose; Epidemiologic Methods; Female; Fetal Blood; Humans; Hypertension; Infant, Newborn; Isradipine; Pregnancy; Pregnancy Complications, Cardiovascular | 2004 |
9 other study(ies) available for atenolol and isradipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Protein markers in evaluation of nephroprotective effects of antihypertensive drugs in patients with arterial hypertension].
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Apolipoproteins; Atenolol; Biomarkers; Complement C3; Complement C4; Female; Haptoglobins; Humans; Hypertension; Immunoglobulin G; Immunoglobulins; Isradipine; Kidney; Male; Middle Aged; Models, Theoretical; Monitoring, Physiologic; Prealbumin; Proteinuria; Ramipril; Transferrin | 2000 |
[Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Atenolol; Calcium Channel Blockers; Depression; Disease Progression; Female; Humans; Isradipine; Male; Myocardial Ischemia; Nitroglycerin; Quality of Life; Risk Factors; Treatment Outcome; Vasodilator Agents | 2005 |